首页|ARHGAP10基因在透明细胞肾癌中的表达水平、预后影响以及免疫作用

ARHGAP10基因在透明细胞肾癌中的表达水平、预后影响以及免疫作用

扫码查看
目的 探讨ARHGAP10基因在透明细胞肾癌(ccRCC)中的表达水平、预后影响以及免疫作用.方法 通过检测癌症基因组图谱(TCGA)数据中ccRCC组织和正常邻近组织中的ARHGAP10表达水平,将所有患者随机分为低表达组(269例)和高表达组(270例).同时通过TIMER数据库验证ARHGAP10的差异表达.采用多变量方法和Kaplan-Meier生存曲线评估ARHGAP表达与临床病理参数和总生存期(OS)的关系.ARHGAP10与相互作用的蛋白质网络使用在线STRING网站构建.使用TIMER和GEPIA数据库研究ARHGAP10表达与浸润免疫细胞及其相应基因标记组之间的关系.结果 低表达组和高表达组的年龄、组织学分级、病理分期、OS等资料比较,差异均有统计学意义(均P<0.05).在TCGA数据库中,与正常组织相比,肿瘤组织中的ARHGAP10基因表达水平显著升高.ARHGAP10基因表达水平与性别、病理分期无相关性(均P>0.05),而与肿瘤浸润深度和是否远处转移具有显著相关性(均P<0.05).ARHGAP10基因低表达的ccRCC患者在测试队列中表示出较短的OS(P<0.001).单因素Cox分析结果显示,ARHGAP10表达与病理学阶段、组织学分级、年龄等都具有显著相关性(均P<0.001).多变量Cox分析结果显示,ARHGAP10表达与年龄、肿瘤浸润深度、远处转移也显著相关(均P<0.05).ARHGAP10的表达水平与ccRCC中CD4+T细胞(r=0.32)、CD8+T细胞(r=0.224)、巨噬细胞(r=0.218)、嗜中性粒细胞(r=0.155)和树突状细胞(r=0.133)的浸润水平呈明显正相关(均P<0.05),但与肿瘤纯度和B细胞无关(均P>0.05).结论 AR-HGAP10表达不足与ccRCC的进展、预后不良和免疫细胞浸润受损有关.
Expression,prognosis,and immune function of ARHGAP10 gene in clear cell renal cell carci-noma
Objective To investigate the expression,prognosis,and immune function of AR-HGAP10 gene in clear cell renal cell carcinoma(ccRCC).Methods By measuring ARHGAP10 ex-pression in ccRCC tissue and normal adjacent tissue in Cancer Genome Atlas(TCGA)data,all pa-tients were randomly divided into a low expression group(269 cases)and a high expression group(270 cases).Meanwhile,the differential expression of ARHGAP10 was verified by the TIMER data-base.The relationship between ARHGAP expression and clinicopathological parameters and overall survival(OS)was evaluated using multivariate methods and Kaplan-Meier survival curve.ARHGAP10 was constructed with a network of interacting proteins using an online STRING website.TIMER and GEPIA databases were used to study the relationship between ARHGAP10 expression and infiltrating immune cells and their corresponding gene markers.Results There were significant differences in age,histological grade,pathological stage and OS between low expression group and high expression group(all P<0.05).In the TCGA database,the expression level of ARHGAP10 gene in tumor tis-sues was significantly higher than that in normal tissues.The expression level of ARHGAP10 gene was not correlated with gender and pathological stage(all P>0.05),but was significantly correlated with tumor invasion depth and distant metastasis(all P<0.05).ccRCC patients with lower ARHGAP10 mRNA expression showed shorter OS in the test cohort(P<0.001).Univariate Cox analysis showed that ARHGAP10 expression was significantly correlated with pathological stage,histological grade and age(all P<0.001).The results of multivariate Cox analysis showed that ARHGAP10 expression was also significantly correlated with age and degree of tumor invasion and distant metastasis(all P<0.05).The expression level of ARHGAP10 was significantly positively correlated that of CD4+T cells(r=0.32),CD8+T cells(r=0.224),macrophages(r=0.218),neutrophils(r=0.155)and den-dritic cells(r=0.133)in ccRCC(all P<0.05),but not with tumor purity and B cells(all P>0.05).Conclusions Insufficient expression of ARHGAP10 is associated with the progression,poor prognosis,and impaired immune cell infiltration of ccRCC.

Carcinoma,Renal CellARHGAP10GenesBiomarker

何虎、陈强、潘进洪、朱建国

展开 >

贵黔国际总医院泌尿外科,贵阳 550018

贵州省人民医院泌尿外科,贵阳 550000

癌,肾细胞 ARHGAP10 基因 生物标志物

2018年贵州省高层次创新人才项目2019年贵阳市科技计划项目2019年贵州省科技计划项目

[2018]5639[2019]2-15[2019]1203

2024

国际泌尿系统杂志
中华医学会,湖南省医学会

国际泌尿系统杂志

CSTPCD
影响因子:0.414
ISSN:1673-4416
年,卷(期):2024.44(5)